Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry
Michael Phillips, Renee N Cataneo, Anirudh Chaturvedi, Peter D Kaplan, Mark Libardoni, Mayur Mundada, Urvish Patel, Xiang Zhang, Michael Phillips, Renee N Cataneo, Anirudh Chaturvedi, Peter D Kaplan, Mark Libardoni, Mayur Mundada, Urvish Patel, Xiang Zhang
Abstract
Background: Comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOF MS) has been proposed as a powerful new tool for multidimensional analysis of complex chemical mixtures. We investigated GCxGC-TOF MS as a new method for identifying volatile organic compounds (VOCs) in normal human breath.
Methods: Samples of alveolar breath VOCs and ambient room air VOC were collected with a breath collection apparatus (BCA) onto separate sorbent traps from 34 normal healthy volunteers (mean age = 40 yr, SD = 17 yr, male/female = 19/15). VOCs were separated on two serial capillary columns separated by a cryogenic modulator, and detected with TOF MS. The first and second dimension columns were non-polar and polar respectively.
Results: BCA collection combined with GC×GC-TOF MS analysis identified approximately 2000 different VOCs in samples of human breath, many of which have not been previously reported. The 50 VOCs with the highest alveolar gradients (abundance in breath minus abundance in ambient room air) mostly comprised benzene derivatives, acetone, methylated derivatives of alkanes, and isoprene.
Conclusions: Collection and analysis of breath VOCs with the BCA-GC×GC-TOF MS system extended the size of the detectable human volatile metabolome, the volatome, by an order of magnitude compared to previous reports employing one-dimensional GC-MS. The size of the human volatome has been under-estimated in the past due to coelution of VOCs in one-dimensional GC analytical systems.
Conflict of interest statement
Competing Interests: Michael Phillips is President and CEO of Menssana Research, Inc. LECO Corporation subsidized the lease of the system to Menssana Research. ML performed this work while employed by LECO.
Figures
References
- Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68: 2374-2376. doi:. PubMed: .
- Vautz W, Nolte J, Bufe A, Baumbach JI, Peters M (2010) Analyses of mouse breath with ion mobility spectrometry: a feasibility study. J Appl Physiol 108: 697-704. doi:. PubMed: .
- Batten JH, Stutte GW, Wheeler RM (1995) Effect of crop development on biogenic emissions from plant populations grown in closed plant growth chambers. Phytochemistry 39: 1351-1357. doi:. PubMed: .
- Schöller C, Molin S, Wilkins K (1997) Volatile metabolites from some gram-negative bacteria. Chemosphere 35: 1487-1495. doi:. PubMed: .
- D’Alessandro M (2006) Assessing the importance of specific volatile organic compounds in multitrophic interactions. Neuchâtel: University of Neuchâtel.
- Sinues PM-L, Kohler M, Zenobi R (2013) Human Breath Analysis May Support the Existence of Individual Metabolic Phenotypes. PLOS ONE 8: e59909. doi:. PubMed: .
- Aghdassi E, Allard JP (2000) Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med 28: 880-886. doi:. PubMed: .
- Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN et al. (2007) Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark 3: 95-109. PubMed: .
- Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P et al. (2010) Volatile biomarkers in the breath of women with breast cancer. J Breath Res 4: 026003. doi:. PubMed: .
- Xu ZQ, Broza YY, Ionsecu R, Tisch U, Ding L et al. (2013) A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer 108: 941-950. doi:. PubMed: .
- Pagonas N, Vautz W, Seifert L, Slodzinski R, Jankowski J et al. (2012) Volatile organic compounds in uremia. PLOS ONE 7: e46258. doi:. PubMed: .
- Phillips M, Basa-Dalay V, Bothamley G, Cataneo RN, Lam PK et al. (2010) Breath biomarkers of active pulmonary tuberculosis. Tuberculosis 90: 145-151. doi:. PubMed: .
- Phillips M (1992) Breath tests in medicine. Scientific American 267: 74-79. PubMed:
- Amann A, Spanĕl P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 7: 115-129. doi:. PubMed: .
- Amann A (2010) Breath 2009: International Dortmund, Germany: Conference on Breath and Breath Odor Research; . Journal of breath research 4: 010201
- Phillips M (1997) Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 247: 272-278. doi:. PubMed: .
- Pierce KM, Hoggard JC, Mohler RE, Synovec RE (2008) Recent advancements in comprehensive two-dimensional separations with chemometrics. J Chromatogr A 1184: 341-352. doi:. PubMed: .
- Libardoni M, Stevens PT, Waite JH, Sacks R (2006) Analysis of human breath samples with a multi-bed sorption trap and comprehensive two-dimensional gas chromatography (GCxGC). J Chromatogr B Anal Technol Biomed Life Sci 842: 13-21. doi:. PubMed: .
- Caldeira M, Perestrelo R, Barros AS, Bilelo MJ, Morête A et al. (2012) Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A 1254: 87-97. doi:. PubMed: .
- Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K et al. (2003) Detection of lung cancer with volatile markers in the breath. Chest 123: 2115-2123. doi:. PubMed: .
- Zhang J, Fang AQ, Wang B, Kim SH, Bogdanov B et al. (2011) iMatch: A retention index tool for analysis of gas chromatography-mass spectrometry data. J Chromatogr A 1218: 6522-6530. doi:. PubMed: .
- Wang B, Fang A, Heim J, Bogdanov B, Pugh S et al. (2010) DISCO: distance and spectrum correlation optimization alignment for two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics. Anal Chem 82: 5069-5081. doi:. PubMed: .
- Kim S, Koo I, Wei X, Zhang X (2012) A method of finding optimal weight factors for compound identification in gas chromatography-mass spectrometry. Bioinformatics 28: 1158-1163. doi:. PubMed: .
- Phillips M, Greenberg J, Sabas M (1994) Alveolar gradient of pentane in normal human breath. Free Radic Res 20: 333-337. doi:. PubMed: .
- Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J et al. (1999) Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 729: 75-88. doi:. PubMed: .
- Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M et al. (2009) Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clinical Chem Laboratory Med CCLM/FESCC 47: 550-560. PubMed: .
- Wallace L, Buckley T, Pellizzari E, Gordon S (1996) Breath measurements as volatile organic compound biomarkers. Environ Health Perspect 104: 861–869. doi:. PubMed: .
- Wishart DS, Knox C, Guo AC, Eisner R, Young N et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-D610. doi:. PubMed: .
Source: PubMed